DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Priority
This application is a 371 of PCT/US2023/076232 filed 10/06/2023 which claims benefit of provisional application 63/414,360 filed 10/07/2022, and claims benefit of provisional application 63/540,847 filed 09/27/2023.
Information Disclosure Statement
The information disclosure statement (IDS) submitted was filed on 09/29/2025. The submission is in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement is being considered by the examiner.
Specification
The abstract of the disclosure is objected to because it does not provide a sufficient summary of the claimed invention and what is new in the art to which the invention pertains. A corrected abstract of the disclosure is required and must be presented on a separate sheet, apart from any other text. See MPEP § 608.01(b).
Applicant is reminded of the proper content of an abstract of the disclosure.
A patent abstract is a concise statement of the technical disclosure of the patent and should include that which is new in the art to which the invention pertains. The abstract should not refer to purported merits or speculative applications of the invention and should not compare the invention with the prior art.
If the patent is of a basic nature, the entire technical disclosure may be new in the art, and the abstract should be directed to the entire disclosure. If the patent is in the nature of an improvement in an old apparatus, process, product, or composition, the abstract should include the technical disclosure of the improvement. The abstract should also mention by way of example any preferred modifications or alternatives.
Where applicable, the abstract should include the following: (1) if a machine or apparatus, its organization and operation; (2) if an article, its method of making; (3) if a chemical compound, its identity and use; (4) if a mixture, its ingredients; (5) if a process, the steps.
Extensive mechanical and design details of an apparatus should not be included in the abstract. The abstract should be in narrative form and generally limited to a single paragraph within the range of 50 to 150 words in length.
See MPEP § 608.01(b) for guidelines for the preparation of patent abstracts.
Claim Objections
Claim 9 is objected to because of the following informalities:
“extravascular location” and “the foreign object” should be corrected to:
“extravascular data” and “a foreign object” respectively
Claim 18 is objected to because of the following informalities:
“OCT” and “NIRS” should be clarified as:
“optical coherence tomography (OCT)” and “near infrared spectroscopy (NIRS)” respectively
Appropriate correction is required.
Claim Rejections - 35 USC § 101
35 U.S.C. 101 reads as follows:
Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title.
Claims 1-11, 16-22, 24-27, 29-30, 35-38, and 43-45 are rejected under 35 U.S.C. § 101 because the claimed invention is directed to an abstract idea without significantly more. Independent claim 1 recites: determining a feature within the intravascular data and a feature within the extravascular data, and registering the feature within the intravascular data and the feature within the extravascular data. The step of determining a feature within the data and registering the feature between the data amounts to a mental process performable in the human mind or with pen and paper. An individual, in their mind, may determine features within data, such as identifying organs or anatomical landmarks in an image. Moreover, an individual may further mentally, or with pen and paper, align the features by visually matching said features or landmarks between images and through rotation/translation, thereby registering said features.
Claim 1 further recites additional elements of acquiring intravascular and extravascular data, and displaying an object relative to the registered feature within the intravascular data or the registered feature within the extravascular data, wherein the object is superimposed on a display of a real-time extravascular data. This judicial exception is not integrated into a practical application because: The step of acquiring of intravascular and extravascular data amounts to mere data gathering, and lastly, displaying of an object by superimposing it amounts to mere communication of data rather than a technological improvement. Accordingly, claim 1 therefore does not include additional elements that are sufficient to amount to significantly more than the judicial exception. MPEP § 2106.04(a)(2) states:
Examples of claims that recite mental processes include:
a claim to "collecting information, analyzing it, and displaying certain results of the collection and analysis," where the data analysis steps are recited at a high level of generality such that they could practically be performed in the human mind, Electric Power Group v. Alstom, S.A., 830 F.3d 1350, 1353-54, 119 USPQ2d 1739, 1741-42 (Fed. Cir. 2016)
Dependent claims 2-8, 16-22, 24-27, 29-30, 35-38, and 43-45 further recite a similar process that, under its broadest reasonably interpretation, covers a mental process. The depending claims do not include additional elements that are sufficient to amount to significantly more than the judicial exception, i.e. integrating the abstract idea into a practical application.
Dependent claims 9-11 recite additional elements of a predictive model, the predictive model comprising a machine learning model, and wherein the machine learning model comprises a neural network algorithm. These models and the neural network algorithms are abstract ideas that fall within the category of mathematical concepts. Claims 9-11 merely applies the mathematical model to analyze data to generate a result (i.e. a location). The claims do not recite any improvement to modeling, machine learning, or neural network algorithms. Therefore, the additional elements do not integrate the abstract idea into a practical application.
Accordingly, claims 1-11, 16-22, 24-27, 29-30, 35-38, and 43-45 are not patent eligible.
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
Claims 1-4, 7-8, 16-17, 19-20, 22, 24, and 26 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Dascal (US20140270436).
Regarding claim 1, Dascal teaches a method for displaying an object ([0015], [0109], wherein a blood vessel and its centerline is displayed), comprising:
acquiring intravascular data and extravascular data ([0066], wherein acquiring angiographic images comprises acquiring extravascular data, [0070], and wherein intravascular images or data is acquired by an imaging catheter which traverses a blood vessel);
determining a feature within the intravascular data and a feature within the extravascular data ([0015], “matching of a feature in an OCT image with a feature in an angiography image”, [0163], wherein bifurcations are detected or determined on OCT images and angiography images);
registering the feature within the intravascular data and the feature within the extravascular data ([0015], “co-registering the angiography images and OCT images based on one or more of…matching of a feature in an OCT image with a feature in an angiography image”, [0163]); and
displaying the object relative to the registered feature within the intravascular data or the registered feature within the extravascular data, wherein the object is superimposed on a display of real-time extravascular data (Figs. 3A-3B, [0109], “a vessel centerline is generated by one or more software modules and superimposed or otherwise displayed relative to the angiography image”, wherein the angiography image includes said feature detected therefrom, i.e. bifurcations, thereby also resulting in the vessel centerline being displayed relative to the registered bifurcation).
Regarding claim 2, Dascal teaches the invention as claimed above in claim 1.
Dascal further teaches wherein the feature within the intravascular data or the feature within the extravascular data are manually selected ([0015], [0163], wherein the feature is bifurcations, [0146], wherein “…perform detection of nearest bifurcation anchor point 170l. This detection step can use the user selected point or hint point as an input…” comprises manually selecting the feature within the extravascular data (angiography image)).
Regarding claim 3, Dascal teaches the invention as claimed above in claim 1.
Dascal further teaches wherein the feature within the intravascular data comprises a location within the intravascular data, and wherein the feature within the extravascular data comprises a location within the extravascular data ([0015], [0163], wherein the feature is bifurcations detected on both images, and bifurcations used as anchor points comprise locations within each image (intravascular and extravascular data)).
Regarding claim 4, Dascal teaches the invention as claimed above in claim 3.
Dascal further teaches wherein the location within the intravascular data and the location within the extravascular data are automatically selected (Figs. 4A-4B & 5B, [0116], “The various steps and stages shown in FIG. 4A and FIG. 4B and as otherwise described herein can be performed automatically in whole or in part in various embodiments”, [0145], “FIG. 5B shows a process flow 170 relating to vessel centerline generation”, [0146], wherein vessel centerline generation which includes determining bifurcation anchor points is a step in figures 4A & 4B, meaning it can be performed automatically in whole).
Regarding claim 7, Dascal teaches the invention as claimed above in claim 1.
Dascal further teaches wherein the intravascular data comprises at least one image (Figs. 3A & 3B, [0007], “OCT images”, [0009], [0083]).
Regarding claim 8, Dascal teaches the invention as claimed above in claim 1.
Dascal further teaches wherein the extravascular data comprises at least one image (Figs. 3A & 3B, [0007], “angiography images”, [0009], [0083]).
Regarding claim 16, Dascal teaches the invention as claimed above in claim 1.
Dascal further teaches wherein the intravascular data comprises optical coherence tomography (OCT), intravascular ultrasound (IVUS), photoacoustic (PA), near infrared spectroscopy (NIRS), fluorescence, autofluorescence (AF), or any combination thereof ([0007], [0063-0064, [0072], wherein intravascular data comprises OCT and/or IVUS).
Regarding claim 17, Dascal teaches the invention as claimed above in claim 1.
Dascal further teaches wherein the intravascular data is detected by a multi-modal imaging system ([0064], “…some embodiments of the invention are suitable for handling multiple imaging modalities. Thus, in part, the invention relates to a multimodal diagnostic system”, [0072], [0091], “The probe 30 can be a variety of types of data collection probes such as for example an OCT probe, an FFR probe, an IVUS probe, a probe combining features of two or more of the foregoing”, [0163]).
Regarding claim 19, Dascal teaches the invention as claimed above in claim 1.
Dascal further teaches wherein the intravascular data is detected by a one-dimensional sensing system ([0062-0063], [0091], [0095], wherein pressure detector sensor which collects pressure data of a blood vessel comprises a one-dimensional sensing system).
Regarding claim 20, Dascal teaches the invention as claimed above in claim 19.
Dascal further teaches wherein the one-dimensional sensing system is a pressure sensing system ([0062-0063], [0091], [0095]).
Regarding claim 22, Dascal teaches the invention as claimed above in claim 1.
Dascal further teaches wherein the real-time extravascular data is streamed directly from an x-ray system (5; 20) without transfer over a network to a processing unit configured to display the object superimposed on the display of the real-time extravascular data ([0009], “frames of angiography are obtained in real time using a frame grabber”, [0011], “an image data processing system that includes a frame grabber”, [0076], “records live angiograms, and displays blood vessels with a contrast agent and the marker or the probe”, [0088], [0089], “In one embodiment, the data processing relating to the collected angiography signal is performed directly on the detector of the angiography system 20. The images from system 20 are stored and managed by the angiography data storage and image management 22”, [0090], [0109], “a vessel centerline is generated by one or more software modules and superimposed or otherwise displayed relative to the angiography image”).
Regarding claim 24, Dascal teaches the invention as claimed above in claim 1.
Dascal further teaches wherein the extravascular data comprises x-ray, CT, magnetic resonance, ultrasound, fluoroscopy, or any combination of data thereof (Abstract, [0002-0003], [0088], [0090], [0165], wherein angiography images are acquired by fluoroscopy which uses x-rays).
Regarding claim 26, Dascal teaches the invention as claimed above in claim 3.
Dascal further teaches wherein the location within the extravascular data is derived from an a priori selection, annotations, or any combination thereof from prior patient records ([0163], wherein the registered locations are bifurcation points, [0125], wherein angiography images are preprocessed to obtain priori information, [0126-0129], [0146], wherein bifurcation points are detected priori and includes user selection).
Claim Rejections - 35 USC § 103
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows:
1. Determining the scope and contents of the prior art.
2. Ascertaining the differences between the prior art and the claims at issue.
3. Resolving the level of ordinary skill in the pertinent art.
4. Considering objective evidence present in the application indicating obviousness or nonobviousness.
Claims 5-6, 25, 35, and 37 are rejected under 35 U.S.C. 103 as being unpatentable over Dascal (US20140270436) in view of Venkatraghavan (US20160196666).
Regarding claim 5, Dascal teaches the invention as claimed above in claim 1.
However, Dascal fails to teach wherein the object comprises a first object and a second object, wherein the first object and the second object are displayed relative to a registered location within the intravascular data or a registered location within the extravascular data.
In an analogous registration and display field of endeavor, Venkatraghavan teaches such a feature. Venkatraghavan teaches registration of intravascular ultrasound (IVUS) images with angiographic images ([0294]). Venkatraghavan teaches tracking one or more markers on a lumen assessment device (Claim 1, [0087]). Venkatraghavan teaches superimposing demarcation positions (positions A and B) and one or more markers upon an image of the body lumen, i.e. blood vessel (Fig. 50B, Claim 25, [0287]). Venkatraghavan therefore teaches a first and second object are displayed (wherein two markers or demarcation positions A and B of a lesion are superimposed) relative to extravascular data (wherein the image of the body lumen is an angiogram, Fig. 50B, [0284], [0287]). As shown in figure 50B the plurality of markers or positions A and B (demarcations of a lesion) are superimposed relative to an extravascular data comprising an angiogram and is thus displayed relative to any feature or registered location in said extravascular data.
It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the invention of Dascal to have the object comprise a plurality of tracked markers or demarcations of a lesion superimposed on extravascular data as taught by Venkatraghavan (Fig. 50B, [0287], claim 25). Tracking and display of the plurality of markers or demarcations of a lesion may help with delivery and deployment of a stent as recognized by Venkatraghavan (Fig. 50B, [0284], [0287]). Modifying Dascal with the teachings of Venkatraghavan would predictably result in superimposing a plurality of markers or demarcations of a lesion on extravascular angiographic images, the markers/demarcations being displayed relative to a registered location within the extravascular/angiographic image.
Regarding claim 6, Dascal teaches the invention as claimed above in claim 1.
However, Dascal fails to explicitly teach the invention further comprising determining a location to guide positioning of a foreign object.
In an analogous registration and display field of endeavor, Venkatraghavan teaches such a feature. Venkatraghavan teaches registration of intravascular ultrasound (IVUS) images with angiographic images ([0294]). Venkatraghavan teaches tracking one or more markers on a lumen assessment device (Claim 1, [0087]). Venkatraghavan teaches using contrast to show on an angiogram the location of a lesion/blockage where a stent needs to be placed ([0284]). Venkatraghavan teaches advancing or guiding the stent delivery catheter to the point of interest and positioning it in place by using the angiographic image as guidance ([0284]). Venkatraghavan therefore teaches determining a location (lesion/blockage) to guide positioning of a foreign object (stent).
It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the invention of Dascal to determine the location of a lesion or blockage where a stent needs to be placed as recognized by Venkatraghavan ([0284]). By determining the location of the blockage, the stent may predictably be delivered to the blockage to widen the vessel, thereby improving the health of the patient or subject.
Regarding claim 25, Dascal teaches the invention as claimed above in claim 3.
However, Dascal fails to teach the invention further comprising measuring heart cycle data from an external ECG signal, intravascular data, extravascular data, or any combination thereof, wherein the heart cycle data is used to improve an accuracy of registration of the location within the intravascular data and the location within the extravascular data to the real-time extravascular data.
In an analogous registration and display field of endeavor, Venkatraghavan teaches such a feature. Venkatraghavan teaches registration of intravascular ultrasound (IVUS) images with angiographic images ([0294]). Venkatraghavan teaches measuring lumen trajectory variation across different phases or points in the heart cycle (Figs. 30-31, [0082-0084]). Venkatraghavan teaches wherein ECG may be used to identify the phase of the heart beat within a heart cycle which an angiographic frame is recorded ([0088]). Venkatraghavan teaches wherein live fluoroscopic images (real-time extravascular data) may be co-registered with a reference angiogram (extravascular data) based on phases of the heart cycle, thereby compensating for motion due to the heart cycle (Claim 15, [0217]). Moreover, Venkatraghavan teaches wherein each recorded image frame recorded with IVUS may be mapped to a corresponding angiographic frame based on the phase of the heartbeat ([0294]), thereby also teaching registering intravascular data with extravascular data based on heart cycle data, resulting in improved accuracy of registration.
It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the invention of Dascal to have ECG track the heart cycle and compensate for motion due to the heart cycle in registration as taught by Venkatraghavan (Claim 15, [0088], [0217], [0294]). Motion artifacts may predictably be corrected for by taking into account of motion from the heart cycle as recognized by Venkatraghavan ([0217]).
Regarding claim 35, Dascal in view of Venkatraghavan teaches the invention as claimed above in claim 5.
However, Dascal fails to teach wherein the first object or second object are displayed superimposed on the real-time extravascular data in one or more views.
In an analogous registration and display field of endeavor, Venkatraghavan teaches such a feature. Venkatraghavan teaches registration of intravascular ultrasound (IVUS) images with angiographic images ([0294]). Venkatraghavan teaches wherein a user may demarcate a lesion and wherein the demarcations (positions A and B) may be superimposed in both static and live angiograms (Fig. 50B, [0287]), wherein positions A and B comprise first and second objects. Venkatraghavan therefore teaches wherein a first object or second object is displayed superimposed on real-time extravascular data in at least one view (Fig. 50B, [0287]).
It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the invention of Dascal to display the demarcations of lesion on live angiograms as taught by Venkatraghavan (Fig. 50B, [0287]). The demarcations may help a user position a balloon catheter as recognized by Venkatraghavan ([0287]).
Regarding claim 37, Dascal in view of Venkatraghavan teaches the invention as claimed above in claim 35.
Dascal further teaches wherein a view of the one or more data views comprises a zoom view ([0078], “The magnifying glass icon can be used to zoom in or out on either the OCT or angiography image”).
Claims 9-11 are rejected under 35 U.S.C. 103 as being unpatentable over Dascal (US20140270436) in view of Kunio (US20220346885).
Regarding claim 9, Dascal teaches the invention as claimed above in claim 1.
However, Dascal fails to teach wherein a location within the intravascular data, a location within the extravascular data, a location to guide positioning of a foreign object, or any combination of locations thereof are determined by a predictive model.
In an analogous method of registering intravascular data with extravascular data field of endeavor, Kunio teaches such a feature. Kunio teaches registering angiography images with ether optical coherence tomography (OCT) images or intravascular ultrasound (IVUS) images ([0023]). Kunio teaches using a predictive model to identify and predict marker locations in angiography image frames ([0013-0014], “In one or more embodiments, a model…trained on data to make one or more predictions… to predict the marker location”). Moreover, Kunio teaches wherein the model comprises a machine learning model ([0013], [0018]). Kunio further teaches wherein the model may comprise a neural network algorithm ([0021], [0027], [0111-0112], [0173]). Kunio therefore teaches determining a location (marker location) within the extravascular data (angiography images) with a predictive model.
It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the invention of Dascal to use a predictive model to identify marker locations as taught by Kunio ([0013-0014]). By using a predictive model, marker locations may be identified more accurately to perform co-registration more efficiently as recognized by Kunio ([0011-0012]).
Regarding claim 10, Dascal in view of Kunio teaches the invention as claimed above in claim 9.
However, Dascal fails to teach wherein the predictive model comprises a machine learning model.
In an analogous method of registering intravascular data with extravascular data field of endeavor, Kunio teaches such a feature. Kunio teaches registering angiography images with ether optical coherence tomography (OCT) images or intravascular ultrasound (IVUS) images ([0023]). Kunio teaches using a predictive model to identify and predict marker locations in angiography image frames ([0013-0014], “In one or more embodiments, a model…trained on data to make one or more predictions… to predict the marker location”). Moreover, Kunio teaches wherein the model comprises a machine learning model ([0013], [0018]). Kunio further teaches wherein the model may comprise a neural network algorithm ([0021], [0027], [0111-0112], [0173]). Kunio therefore teaches wherein the predictive model comprises a machine learning model.
It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the invention of Dascal to use a machine learning model to identify marker locations as taught by Kunio ([0013-0014]). By using a machine learning model, marker locations may be identified more accurately to perform co-registration more efficiently as recognized by Kunio ([0011-0012]).
Regarding claim 11, Dascal in view of Kunio teaches the invention as claimed above in claim 10.
However, Dascal fails to teach wherein the machine learning model comprises a neural network algorithm.
In an analogous method of registering intravascular data with extravascular data field of endeavor, Kunio teaches such a feature. Kunio teaches registering angiography images with ether optical coherence tomography (OCT) images or intravascular ultrasound (IVUS) images ([0023]). Kunio teaches using a predictive model to identify and predict marker locations in angiography image frames ([0013-0014], “In one or more embodiments, a model…trained on data to make one or more predictions… to predict the marker location”). Moreover, Kunio teaches wherein the model comprises a machine learning model ([0013], [0018]). Kunio further teaches wherein the model may comprise a neural network algorithm ([0021], [0027], [0111-0112], [0118-0119], [0173]). Kunio therefore teaches wherein machine learning model comprises a neural network algorithm.
It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the invention of Dascal to have the machine learning model comprise a neural network algorithm as taught by Kunio ([0021], [0027], [0111-0112], [0118-0119], [0173]). Success rate of marker detection may be improved using a neural network model as recognized by Kunio ([0118-0119]), thereby improving co-registration efficiency.
Claim 12 rejected under 35 U.S.C. 103 as being unpatentable over Dascal (US20140270436) in view of Baldauf (US20180310992).
Regarding claim 12, Dascal teaches the invention as claimed above in claim 1.
However, Dascal fails to teach the invention further comprising guiding a catheter through a coronary artery to the object to treat coronary artery disease.
In an analogous intravascular field of endeavor, Baldauf teaches such a feature. Baldauf teaches reconstruction of an arterial lumen using intravascular data such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) ([0027]). Moreover, Baldauf teaches observing or displaying markers of a catheter (100) on an angiogram ([0028-0029]). Baldauf teaches treatment of coronary artery disease (CAD) comprises insertion of a catheter and stent into a coronary artery ([0003-0004]). Baldauf teaches threading a catheter onto a guidewire and directing the catheter through a coronary artery to a location of interest such as stenosis ([0032]). Since the stenosis is a location for treating CAD, Baldauf therefore teaches guiding a catheter through a coronary artery to an object (blood vessel/stenosis) to treat coronary artery disease.
It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the invention of Dascal to guide a catheter to a stenosis in a coronary artery to treat coronary artery disease as taught by Baldauf ([0003-0004], [0032]). By guiding a catheter to a stenosis of the coronary artery, a stent may be placed at the stenosis using the catheter, thereby holding the artery open and improving patient health as recognized by Baldauf ([0004]).
Claims 14-15 and 21 are rejected under 35 U.S.C. 103 as being unpatentable over Dascal (US20140270436) in view of Fan (US20140236011).
Regarding claim 14, Dascal teaches the invention as claimed above in claim 1.
However, Dascal fails to teach guiding a catheter through a coronary artery to the object to diagnose coronary artery disease.
In an analogous intravascular field of endeavor, Fan teaches such a feature. Fan teaches methods for accurate diagnosis of coronary artery disease ([0018]). Fan teaches calculating fractional flow reserve across a stenosis in a blood vessel (102) (FFR) ([0042-0043], [0052-0053]). Fan teaches, conventionally, passing a transducer of a FFR catheter across a coronary lesion and calculating FFR ([0053]). Fan teaches an integrated device (300) including a catheter (104) configured to measure FFR in a blood vessel (102) (i.e. coronary artery) (Fig. 3, [0011], [0042-0043], [0046-0047]). Fan therefore teaches guiding a catheter through a coronary artery (wherein FFR catheter is guided to a coronary lesion) to an object (lesion) to diagnose coronary artery disease.
It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the invention of Dascal to guide a catheter through a coronary artery to calculate fractional flow reserve (FFR) as taught by Fan (Fig. 3, [0011], [0018], [0042-0043], [0046-0047], [0052-0053]). By guiding a catheter to a coronary artery, lesion, or blockage, FFR may be calculated and be predictably used to diagnose coronary artery disease (CAD), and diagnosing CAD may predictably improve patient outcomes.
Regarding claim 15, Dascal in view of Fan teaches the invention as claimed above in claim 14.
However, Dascal fails to teach wherein the catheter comprises a catheter to measure fractional flow reserve of the coronary artery.
In an analogous intravascular field of endeavor, Fan teaches such a feature. Fan teaches methods for accurate diagnosis of coronary artery disease ([0018]). Fan teaches calculating fractional flow reserve across a stenosis in a blood vessel (102) (FFR) ([0042-0043], [0052-0053]). Fan teaches, conventionally, passing a transducer of a FFR catheter across a coronary lesion and calculating FFR ([0053]). Fan teaches an integrated device (300) including a catheter (104) configured to measure FFR in a blood vessel (102) (i.e. coronary artery) (Fig. 3, [0011], [0042-0043], [0046-0047], [0052], [0054], [0070-0071]). Fan therefore teaches a catheter to measure fractional flow reserve of the coronary artery.
It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the invention of Dascal to use a catheter configured for measuring fractional flow reserve (FFR) of a coronary artery as taught by Fan (Fig. 3, [0011], [0042-0043], [0046-0047], [0054], [0070-0071]). FFR is a diagnostic parameter that may provide indication of a pathological condition, such as coronary artery disease, as recognized by Fan ([0018], [0070]).
Regarding claim 21, Dascal teaches the invention as claimed above in claim 1.
However, Dascal fails to teach wherein the intravascular data comprises a measure of flow.
In an analogous intravascular field of endeavor, Fan teaches such a feature. Fan teaches a system (100) including a catheter (104) having a flow sensor (107) for measuring blood flow through a blood vessel (102) ([0021-0022]). Fan teaches wherein the system may be implemented as an IVUS, OCT, or ICE system ([0020]).
It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the invention of Dascal to measure blood flow as taught by Fan ([0021-0022]). Measuring of blood flow through a vessel may predictably be used to diagnose the health of the vessel.
Claim 18 is rejected under 35 U.S.C. 103 as being unpatentable over Dascal (US20140270436) in view of Muller (US20090299195).
Regarding claim 18, Dascal teaches the invention as claimed above in claim 17.
However, Dascal fails to teach wherein the multi-modal imaging system comprises a combined OCT and NIRS imaging system.
In an analogous intravascular field of endeavor, Muller teaches such a feature. Muller teaches a multimodal catheter system for intravascular analysis (Title). Muller teaches a single catheter combining multiple diagnostic modalities ([0014]). Muller teaches wherein the catheter (100) is configured to collect OCT and NIR data for analysis ([0016], [0046-0049], [0052], [0055-0057], [0067-0068]). Muller further teaches registration of angiography with other imaging modalities such as NIR, OCT, IVUS ([0017], [0072]).
It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the invention of Dascal to configure the catheter for OCT and NIRS as taught by Muller ([0016], [0046-0049], [0052], [0055-0057], [0067-0068]). A catheter or imaging system which combines both NIRS and OCT may provide a physician with more comprehensive data set to formulate a therapy decision as recognized by Muller ([0015-0016]).
Claim 27 is rejected under 35 U.S.C. 103 as being unpatentable over Dascal (US20140270436) in view of Strommer (US20050107688) and Venkatraghavan (US20160196666).
Regarding claim 27, Dascal teaches the invention as claimed above in claim 1.
Dascal further teaches real-time extravascular data are displayed ([0076], wherein angiograms are recorded live and displayed).
However, Dascal fails to teach wherein the object comprises a fiducial marker.
In an analogous method of displaying of an object field of endeavor, Strommer teaches such a feature. Strommer teaches displaying of a real-time 2D image (104) via x-ray fluoroscopy or angiogram (Fig. 1A, [0062-0063]). Strommer further teaches wherein fiducial markers attached to a catheter may be displayed on the real-time image (104) of the lumen (108) ([0070]). Strommer therefore teaches wherein the displayed object is a fiducial marker and wherein the marker is displayed on a real-time extravascular data/image.
It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the invention of Dascal to have the displayed object be fiducial markers as taught by Strommer ([0070]). By displaying fiducial markers attached to an instrument, an operator may continue to use the real-time image for guidance even with little to no contrast as recognized by Strommer ([0070]).
However, the modified combination noted above fails to teach wherein the spatial position of the fiducial marker is adjusted to account for motion artifacts.
In an analogous registration and display field of endeavor, Venkatraghavan teaches such a feature. Venkatraghavan teaches registration of intravascular ultrasound (IVUS) images with angiographic images ([0294]). Venkatraghavan teaches tracking one or more markers on a lumen assessment device (Claim 1, [0087]). Venkatraghavan teaches superimposing the one or more markers upon an image of the body lumen, i.e. blood vessel (Fig. 50B, Claim 25, [0287]). Venkatraghavan teaches mapping or registering a detected position of a device onto an image after compensating for motion due to heart beat, breathing, and other minor movements ([0072]). Venkatraghavan teaches the position of the device is based on the markers ([0130]). Venkatraghavan teaches compensating for motion of the markers of the instrument during registration (Claim 1, [0225]). Venkatraghavan therefore teaches correcting a spatial position of a device and its markers to account for motion artifacts.
It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the invention of Dascal in view of Strommer to correct the position of objects, i.e. device and its markers, for motion artifacts as taught by Venkatraghavan (Claim 1, [0072] [0130], [0225]). By compensating for motion artifacts due to heart beat, breathing, and the like, a more accurate registration and depiction/display of objects may predictably be obtained.
Claim 29 is rejected under 35 U.S.C. 103 as being unpatentable over Dascal (US20140270436) in view of Cohen (US20230181140).
Regarding claim 29, Dascal teaches the invention as claimed above in claim 1.
However, Dascal fails to teach the invention further comprising measuring a distance from a catheter to the object.
In an analogous registration of intravascular data to extravascular data field of endeavor, Cohen teaches such a feature. Cohen teaches registering imaging data from an intravascular imaging catheter to locations in an x-ray image (Abstract, [0006]). Cohen teaches measuring the distance from a catheter to a vessel wall (object) ([0135]).
It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the invention of Dascal to measure a distance from a catheter to a vessel wall as taught by Cohen ([0135]). By measuring the distance, lines may be drawn estimating vessel wall location, thereby helping visualization of the vessel wall to a user for guidance as recognized by Cohen (Fig. 12, [0135]).
Claim 30 is rejected under 35 U.S.C. 103 as being unpatentable over Dascal (US20140270436) in view of Cohen (US20230181140) as applied to claim 29 above, and further in view of Lu (US20220175269).
Regarding claim 30, Dascal in view of Cohen teaches the invention as claimed above in claim 29.
However, Dascal fails to explicitly teach wherein the measured distance from the catheter to the object is displayed in real time with a visual representation.
In an analogous method comprising acquiring of extravascular data field of endeavor, Lu teaches such feature. Lu teaches acquiring and displaying x-ray angiogram images of coronary vessels ([0028], [0102], [0116]). Lu teaches distance measurements may be integrated with angiogram vasculature imaging ([0260]). Lu teaches wherein distance measurements can be calculated and displayed in real-time ([0260]). Lu therefore teaches displaying distance measurements in real time, and wherein displaying implies visual representation.
It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the invention of Dascal in view of Cohen to display the distance measurements in real time as taught by Lu ([0260]). Display of real time distance data may predictably help a user with guidance of the catheter in real time for a procedure.
Claims 36 and 38 are rejected under 35 U.S.C. 103 as being unpatentable over Dascal (US20140270436) in view of Venkatraghavan (US20160196666) as applied to claim 35 above, and further in view of Millett (US20140187920).
Regarding claim 36, Dascal in view of Venkatraghavan teaches the invention as claimed above in claim 35.
However, Dascal fails to teach wherein a first view of the one or more data views comprises a display of the real-time extravascular data without a display of the first object or the second object, and wherein a second view of the one or more data views comprises a display of the real-time extravascular data with a display of the first object or the second object.
In an analogous registration of intravascular data to extravascular data field of endeavor, Millett teaches such a feature. Millet teaches co-registration of intravascular data with angiographic images ([0047]). Millett teaches a user is able to select what information should be included or excluded from a displayed image ([0066]). Millett teaches a user may select visualization modes ([0066]). Millett teaches wherein a user may either show or hide various data such as graphs, data, or overlaid data ([0066]). Millett therefore teaches a first and second view, wherein a first view may hide objects and wherein a second view may show objects.
It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the invention of Dascal to have a user be able to hide or show certain objects or data on a displayed image as taught by Millett ([0066]). Hiding or showing data may be useful when relevant data is needed or isn’t needed and the image needs to clearer/less obscured by the data.
Regarding claim 38, Dascal in view of Venkatraghavan teaches the invention as claimed above in claim 35.
However, Dascal fails to teach wherein displaying the first object or the second object relative to the registered location within the intravascular data or the registered location within the extravascular data comprises a first state, wherein the display of the first object or the second object is visible, or a second state, wherein the display of the first object or the second object is not visible.
In an analogous registration of intravascular data to extravascular data field of endeavor, Millett teaches such a feature. Millet teaches co-registration of intravascular data with angiographic images ([0047]). Millett teaches a user is able to select what information should be included or excluded from a displayed image ([0066]). Millett teaches a user may select visualization modes ([0066]). Millett teaches wherein a user may either show or hide various data such as graphs, data, or overlaid data ([0066]). Millett therefore teaches first and second states, wherein a first state may display objects and wherein a second state may hide objects.
It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the invention of Dascal to have a user be able to show or hide certain objects or data on a displayed image as taught by Millett ([0066]). Showing and hiding data may be useful when relevant data is needed or isn’t needed and the image needs to clearer/less obscured by the data.
Claims 43 and 44 are rejected under 35 U.S.C. 103 as being unpatentable over Dascal (US20140270436) in view of Simaan (US20240277423).
Regarding claim 43, Dascal teaches the invention as claimed above in claim 1.
Dascal teaches wherein real-time extravascular data is angiograms ([0009], [0076], “…records live angiograms, and displays blood vessels”).
However, Dascal fails to teach the invention further comprising displaying an indicator, wherein the indicator comprises a metric representing a distance between the object and a target location within the real-time extravascular data.
In an analogous acquiring of extravascular data field of endeavor, Simaan teaches such a feature. Simaan teaches displaying a color bar with a numerical distance indicator, wherein the color bar changes color as a catheter tip (object) approaches a target and is representative of the distance between the catheter and target (Claim 6, [0085]). Simaan teaches wherein the target may comprise a clot or aneurysm wall and wherein the location of the target is deduced from an angiogram, therefore teaching wherein the target is a target location within an angiogram (Fig. 1, [0003], [0033]). Dascal above teaches wherein the real-time extravascular data comprises live angiograms.
It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the invention of Dascal to display a numerical indicator indicating a distance between a tip of a catheter to a target as recognized by Simaan (Claim 6, [0085]). The distance indicator may predictably help a user know how much further to advance the catheter to said target for treatment.
Regarding claim 44, Dascal in view of Simaan teaches the invention as claimed above in claim 43.
However, Dascal fails to teach wherein the target location is determined by at least one intravascular image or at least one extravascular image.
In an analogous acquiring of extravascular data field of endeavor, Simaan teaches such a feature. Simaan teaches displaying a color bar with a numerical distance indicator, wherein the color bar changes color as a catheter tip (object) approaches a target and is representative of the distance between the catheter and target (Claim 6, [0085]). Simaan teaches wherein the target may comprise a clot or aneurysm wall and wherein the location of the target is deduced from an angiogram (Fig. 1, [0003], [0033]).
It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the invention of Dascal to derive the target location from extravascular data as taught by Simaan (Fig. 1, [0003], [0033]). A location of a clot may be deduced from the absence of contrast in an angiogram as recognized by Simaan ([0033]), allowing for using a catheter to remove said clot via aspiration/vacuum as further recognized by Simaan ([0005]).
Claim 45 is rejected under 35 U.S.C. 103 as being unpatentable over Dascal (US20140270436) in view of Venkatraghavan (US20160196666) as applied to claim 35 above, and further in view of Weese (US20080192887).
Regarding claim 45, Dascal in view of Venkatraghavan teaches the invention as claimed above in claim 35.
However, Dascal fails to teach the invention further comprising processing a vessel geometry of the extravascular data and displaying the processed vessel geometry in a view of the one or more data views.
In an analogous method including acquiring of extravascular data field of endeavor, Weese teaches such a feature. Weese teaches extracting features related to vessel geometry from X-ray projections ([0007], wherein x-ray projections comprise extravascular data). Weese teaches a data processing unit adapted to reconstruct a three-dimensional model of vessel geometry (Claim 1, [0005], [0017]). Weese teaches displaying the reconstructed vessel geometry (Claim 11, [0025]). Weese therefore teaches processing (reconstructing) a vessel geometry of the extravascular data (x-ray projections of the vessel system) and displaying the processed (reconstructed) vessel geometry in a view of the one or more data views, wherein a view is implied from displaying.
It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the invention of Dascal to reconstruct and display vessel geometry as taught by Weese (Claims 1 & 11, [0005], [0007], [0017], [0025]). Processing and display of vessel geometry may predictably help a user guide a catheter or instrument through the vessel for diagnosis or treatment.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to TOMMY T LY whose telephone number is (571) 272-6404. The examiner can normally be reached M-F 12:00pm-8:00pm eastern time.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anhtuan Nguyen can be reached at 571-272-4963. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/TOMMY T LY/ Examiner, Art Unit 3797
/SERKAN AKAR/ Primary Examiner, Art Unit 3797